MoneyWorks4Me

Natco Pharma informs about press release

02 Jan 2017 Evaluate

Natco Pharma has informed about a Press Release dated January 02, 2017 titled ‘NATCO launches VELPANAT in Nepal- 1st generic version of Sofosbuvir 400mg/Velpatasvir 100mg fixed dose combination medicine in the country’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..